View source for Guidelines for the indications to test for and to treat Helicobacter pylori infection

__NOTOC__

{{CMG}}; {{AE}} {{MKK}}, {{SSW}}
{{Peptic ulcer }}
==2017 ACG guidelines for the indications to test for and to treat Helicobacter pylori infection==
{| class="wikitable" 
|-
| colspan="1" style="text-align:center; background:LightGreen" |Strong recommendation
|-
| bgcolor="LightGreen" |1.Since all patients with a positive test of active [[infection]] with [[H. pylori]] should be offered treatment, the critical issue is which patients should be tested for the
[[infection]].

|-
| bgcolor="LightGreen" |2.All patients with active [[peptic ulcer disease]] (PUD), a past history of PUD (unless previous cure of [[Helicobacter pylori infection|H. pylori infection]] has been documented), low-grade
gastric mucosa-associated lymphoid tissue lymphoma  ([[MALT lymphoma|MALT]])or a history of endoscopic resection of early [[Gastric cancer|gastric cance]]<nowiki/>r (EGC) should be tested for [[Helicobacter pylori infection|H.]]

[[Helicobacter pylori infection|pylori infection]]. Those who test positive should be offered treatment for the [[infection]].
|-
| bgcolor="LightGreen" |'''3.''' When upper [[endoscopy]] is undertaken in patients with [[dyspepsia]], [[gastric]] biopsies should be taken to evaluate for [[Helicobacter pylori infection|H. pylori infection]]. [[Infected]] patients
should be offered eradication therapy.
|-
| bgcolor="LightGreen" |
4.Patients with typical symptoms of [[gastroesophageal reflux disease]] (GERD) who do not have a history of [[PUD]] need not be tested for [[Helicobacter pylori infection|H. pylori infection]].

However, for those who are tested and found to be infected, treatment should be offered, acknowledging that effects on [[GERD]] symptoms are unpredictable.
|-
| bgcolor="LightGreen" |5.Patients initiating chronic treatment with a [[non-steroidal anti-inflammatory drug]] (NSAID) should be tested for [[Helicobacter pylori infection|H. pylori infection]]. Those who test positive
should be offered eradication therapy.<ref name="urlwww.nature.com2">{{cite web |url=https://www.nature.com/ajg/journal/v112/n2/pdf/ajg2016563a.pdf |title=www.nature.com |format= |work= |accessdate=}}</ref>
|-
|}

{| class="wikitable" 
|-
| colspan="1" style="text-align:center; background:LemonChiffon" |Conditional recommendation
|-
| bgcolor="LemonChiffon" |'''1.'''In patients with uninvestigated [[dyspepsia]] who are under the age of 60 years and without alarm features, non-endoscopic testing for [[Helicobacter pylori infection|H. pylori infection]] is a
consideration. Those who test positive should be offered eradication therapy.
|-
| bgcolor="LemonChiffon" |2.In patients taking long-term, low-dose aspirin, testing for [[Helicobacter pylori infection|H. pylori infection]] could be considered to reduce the risk of [[ulcer]] [[bleeding]]. Those who test positive
should be offered eradication therapy to reduce the risk of ulcer bleeding.
|-
| bgcolor="LemonChiffon" |3.The benefit of testing and treating [[Helicobacter pylori infection|H. pylori infection]] in a patient already taking an [[NSAID]] remains unclear.
|-
|-
| bgcolor="LemonChiffon" |4.Patients with unexplained [[iron deficiency anemia]] despite an appropriate evaluation should be tested for [[Helicobacter pylori infection|H. pylori infection]]. Those who test positive should
be offered eradication therapy.
|-
| bgcolor="LemonChiffon" |5.Adults with [[idiopathic thrombocytopenic purpura]] (ITP) should be tested for [[Helicobacter pylori infection|H. pylori infection]]. Those who test positive should be offered eradication
therapy.<ref name="urlwww.nature.com">{{cite web |url=https://www.nature.com/ajg/journal/v112/n2/pdf/ajg2016563a.pdf |title=www.nature.com |format= |work= |accessdate=}}</ref>
|}


==References==
{{reflist|2}}